Company Email Format Management

Cellvie

Biotechnology Research Zuerich, Ch 13 employees

Employees: 13
Contacts: 1
Emails: 1

cellvie.bio LinkedIn Crunchbase

Cellvie Overview

Headquarters: Zuerich, Ch
Website: cellvie.bio
Industry: Biotechnology Research
Employees: 13
Founded: 2018
Funding: 5.5M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Therapeutic Mitochondria Transfer Mitochondria Ischemia-Reperfusion Injury Solid Organ Transplantation

About Cellvie

cellvie is the leader in Therapeutic Mitochondria Transplantation (TMT). The team is seeking to bring about a novel treatment modality, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell. Therapeutic Mitochondria Transplantation, an approach for mitochondria augmentation and replacement, was developed by Dr. James McCully at Harvard Medical School. cellvie was founded to take this technology from bench to bed, starting in heart attacks and solid organ transplantation.

Cellvie Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

Cellvie Org Chart

Sample employees and titles

Name	Title	Location	Contact
Dr. Alexander Schueller	Founder & CEO @ Cellvie Inc.		View
Dedy Septiadi, Phd	Senior Principal Scientist at Cellvie	Zurich, Switzerland	View
Tobias Sedlmeier			View
Stephen Helliwell		Basel, Switzerland	Email